A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis-Reference-Cited by-同舟云学术

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

Published:2015-03 Issue:3 Volume:13 Page:531-538
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Arias Maria Theresa,Vande Casteele Niels,Vermeire Séverine,de Buck van Overstraeten Anthony,Billiet Thomas,Baert Filip,Wolthuis Albert,Van Assche Gert,Noman Maja,Hoffman Ilse,D’Hoore Andre,Gils Ann,Rutgeerts Paul,Ferrante Marc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

2. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab;Sandborn;Gastroenterology,2009

3. Clinical trial: colectomy after rescue therapy in ulcerative colitis–3-year follow-up of the Swedish-Danish controlled infliximab study;Gustavsson;Aliment Pharmacol Ther,2010

4. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study;Jarnerot;Gastroenterology,2005

5. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial;Laharie;Lancet,2012

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis;Expert Review of Gastroenterology & Hepatology;2024-08-28

2. Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach;International Journal of Molecular Sciences;2024-05-18

3. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

4. C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis;Frontiers in Medicine;2024-03-12

5. Longitudinal Measurements of Blood Biomarkers in Patients with Crohn’s Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure;Journal of Clinical Medicine;2024-02-06